We are live on ! Find out more
ACAD icon

Acadia Pharmaceuticals

210 hedge funds and large institutions have $3.61B invested in Acadia Pharmaceuticals in 2017 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 82 increasing their positions, 64 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

28% more repeat investments, than reductions

Existing positions increased: 82 | Existing positions reduced: 64

0.38% more ownership

Funds ownership: 96.25%96.63% (+0.38%)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0% more first-time investments, than exits

New positions opened: 36 | Existing positions closed: 36

1% less funds holding

Funds holding: 212210 (-2)

19% less capital invested

Capital invested by funds: $4.44B → $3.61B (-$825M)

30% less call options, than puts

Call options by funds: $24.9M | Put options by funds: $35.6M

Holders
210
Holders Change
-2
Holders Change %
-0.94%
% of All Funds
4.76%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.09%
New
36
Increased
82
Reduced
64
Closed
36
Calls
$24.9M
Puts
$35.6M
Net Calls
-$10.7M
Net Calls Change
+$16.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Massachusetts Financial Services
51
Massachusetts Financial Services
Massachusetts
$5.48M +$77.2K +2,414 +1%
SFM
52
Sphera Funds Management
Israel
$5.12M +$5.44M +170,000 New
Swiss National Bank
53
Swiss National Bank
Switzerland
$5.02M +$125K +3,900 +2%
California Public Employees Retirement System
54
California Public Employees Retirement System
California
$4.78M +$179K +5,600 +4%
LPL Financial
55
LPL Financial
California
$4.78M +$2.1M +65,517 +70%
California State Teachers Retirement System (CalSTRS)
56
California State Teachers Retirement System (CalSTRS)
California
$4.69M +$11.4K +357 +0.2%
Wells Fargo
57
Wells Fargo
California
$4.44M -$809K -25,297 -15%
GC
58
Guggenheim Capital
Illinois
$4.4M -$516K -16,151 -10%
State Board of Administration of Florida Retirement System
59
State Board of Administration of Florida Retirement System
Florida
$4.02M +$49.2K +1,540 +1%
Group One Trading
60
Group One Trading
Illinois
$4.01M -$4.47M -139,795 -51%
GGHC
61
Gilder Gagnon Howe & Co
New York
$3.39M -$337K -10,545 -9%
RhumbLine Advisers
62
RhumbLine Advisers
Massachusetts
$3.26M -$87.4K -2,734 -2%
AllianceBernstein
63
AllianceBernstein
Tennessee
$2.96M -$4.8K -150 -0.2%
Barclays
64
Barclays
United Kingdom
$2.92M -$1.88M -58,660 -38%
ACP
65
Acuta Capital Partners
California
$2.71M -$2.56M -80,000 -47%
JG
66
Jefferies Group
New York
$2.67M -$582K -18,200 -17%
FCM
67
Frontier Capital Management
Massachusetts
$2.64M -$10.2M -318,787 -78%
Millennium Management
68
Millennium Management
New York
$2.61M +$803K +25,112 +41%
VOYA Investment Management
69
VOYA Investment Management
Georgia
$2.56M +$1.2M +37,561 +79%
CS
70
Credit Suisse
Switzerland
$2.52M -$4.52M -141,500 -63%
Citadel Advisors
71
Citadel Advisors
Florida
$2.37M +$44.1K +1,380 +2%
PVAM
72
Pacific View Asset Management
California
$2.32M +$2.47M +77,113 New
CS
73
Candriam SCA
Luxembourg
$2.32M
Squarepoint
74
Squarepoint
New York
$2.28M +$1.35M +42,357 +127%
GBA
75
Garrison Bradford & Associates
New York
$2.23M +$25.6K +800 +1%

ACAD Hedge Fund Activity: Q4 2017 in Review

210 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Acadia Pharmaceuticals (ACAD) for Q4 2017, worth a combined $3.61B — down 19% from $4.44B a quarter earlier.

Fund positioning in ACAD was balanced in Q4 2017: 36 funds opened new positions, 36 closed out, 82 added to existing stakes and 64 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $53.4M. The largest seller was Senator Investment Group, exiting entirely with an estimated $54.4M sold.

  • 210 institutional investors held Acadia Pharmaceuticals (ACAD) as of Q4 2017, down from 212 in Q3 2017.
  • Funds reported $3.61B of Acadia Pharmaceuticals stock for Q4 2017, down 19% quarter-over-quarter.
  • 36 funds opened new Acadia Pharmaceuticals positions in Q4 2017 and 36 closed out, a net change of 0 holders.
  • The largest Acadia Pharmaceuticals buyer in Q4 2017 was Point72 Asset Management, an estimated $53.4M added.
  • The largest Acadia Pharmaceuticals seller in Q4 2017 was Senator Investment Group, an estimated $54.4M sold.

Based on aggregated 13F filings for Q4 2017.